Awards & Accreditations

Domainex is an award-winning integrated drug discovery services provider. In recent years we have been recognised by a range of industry bodies, celebrating our success as a team and as a business.

King's Award for Enterprise: International Trade 2023

Domainex has received a King’s Award for Enterprise: International Trade 2023. This prestigious award recognises the company’s outstanding growth in international trade over three years (2019-2021) which amounted to a more than one hundred per cent increase in international revenues during the period. 

Find out more in the following press releases:

HM Lord-Lieutenant of Cambridgeshire Opens Domainex’s New Biology Centre of Excellence and Presents the King’s Award for Enterprise

Domainex secures a prestigious King’s Award for Enterprise

Best Drug Discovery Services Provider 2023

Domainex has been awarded the Best Drug Discovery Services Provider 2023 at the Global Health & Pharma Global Excellence Awards.

Cambridge Independent SME Awards 2023

Domainex was awarded Gold for High Growth Business of the Year and Silver for Business of the Year (>50 employees).

Business Weekly Awards

Domainex was honoured to receive the Life Sciences Scale-up Award 2023.

Best Drug Development, Discovery and Contract Research Organisation, 2022 - United Kingdom

Domainex has been awarded the Best Drug Development, Discovery and Contract Research Organisation, 2022 - United Kingdom at the Global Health and Pharma Global Excellence Awards.

SME National Business Awards 2022

Following success in the Cambridge regional awards, Domainex went on to win the Silver award for High Growth in the National Awards. 

Cambridge Independent SME Awards 2022

Domainex was awarded a Gold award for High Growth Business of the Year and a Silver award for Business of the Year (more than 50 employees). 

Leading Providers of Integrated Drug Delivery Services 2022

Domainex has been awarded the Leading Providers of Integrated Drug Delivery Services 2022 in the Global Health and Pharma International Life Sciences Awards.

Most Innovative Drug Discovery CRO 2022

Domainex has been awarded the Most Innovative Drug Discovery CRO 2022 in the Healthcare and Pharmaceutical Awards, gaining recognition for the third year in a row. 

Best Drug Discovery CRO 2021

Domainex has been awarded the Best Drug Discovery CRO 2021 in the Healthcare and Pharmaceutical Awards 2021. After our success in 2020, Global Health & Pharma’s team of judges have recognised our services in this sector for the second year running.

Domainex wins Best Drug Discovery CRO 2021 in the Global Health & Pharma Healthcare and Pharmaceutical Awards 2021, marking two years of recognition in this sector 

2021 Freezer Challenge - Individual Laboratory Winner

Our Bioscience lab won a 2021 Freezer Challenge award, saving 48 kWh/day! The challenge is designed to encourage labs to optimise the sustainability of cold storage management and help change practices for the benefit of our environment.

Best CRO 

We were named the Best CRO at the postponed OBN Awards 2020, awarded in June 2021. Following a very challenging period during the pandemic, the judges recognised our customer focus and the award would not have been possible without the hard work of our fantastic team. This is what allows Domainex to offer high quality services and remain a leader in the field of drug discovery.

Domainex wins Best CRO at OBN Awards

Drug Discovery CRO of the Year – Europe

At the Healthcare & Pharmaceutical Awards 2020, hosted by Global Health & Pharma (GHP), Domainex was awarded Drug Discovery CRO of the Year – Europe, recognising Domainex’s contribution to the industry and reflecting our expertise in drug discovery, dedication to customer service and commitment to promoting excellence.

Domainex recognised as leading drug discovery CRO

FT 1000

Domainex was ranked within the top 1000 fastest growing companies in Europe by the Financial Times in 2018. We were the only drug discovery CRO to have made this list.

Domainex ranked as the fastest growing drug discovery CRO in Europe